Lipoid Proteinosis: A Previously Unrecognized Mutation and Therapeutic Response to Acitretin

Acta Derm Venereol. 2017 Nov 15;97(10):1249-1251. doi: 10.2340/00015555-2752.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acitretin / administration & dosage*
  • Acitretin / adverse effects
  • Administration, Oral
  • Adolescent
  • DNA Mutational Analysis
  • Extracellular Matrix Proteins / genetics*
  • Genetic Predisposition to Disease
  • Humans
  • Keratolytic Agents / administration & dosage*
  • Keratolytic Agents / adverse effects
  • Lipoid Proteinosis of Urbach and Wiethe / diagnosis
  • Lipoid Proteinosis of Urbach and Wiethe / drug therapy*
  • Lipoid Proteinosis of Urbach and Wiethe / genetics*
  • Male
  • Mutation*
  • Phenotype
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • ECM1 protein, human
  • Extracellular Matrix Proteins
  • Keratolytic Agents
  • Acitretin